Literature DB >> 238050

Serologic evidence of Venezuelan equine encephalitis in some wild and domestic populations of southern Texas.

D L Smart, D O Trainer.   

Abstract

More than 2,500 sera from approximately 30 wild and domestic species in southern Texas were tested for neutralizing antibodies to Venezuelan equine encephalitis (VEE). Virus isolations were also attempted from blood and tissue samples of many of the wild specimens. VEE neutralizing substances were present in a variety of species collected prior to the 1971 epizootic, suggesting that VEE was present and perhaps enzootic in this area before the recent epizootic. Serologic results of this study suggest that deer (Odocoileus virginianus) and feral swine (Sus scrofa) may serve as good indicators or sentinels of VEE transmission. The reservoir of VEE was not established, but results of the study suggest that a number of species or a combination of animal host populations including deer, feral swine, and peccaries (Pecari angulatus) may be involved in the eizootiologyof VEE in southern Texas.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238050     DOI: 10.7589/0090-3558-11.2.195

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  3 in total

Review 1.  DNA-launched live-attenuated vaccines for biodefense applications.

Authors:  Peter Pushko; Igor S Lukashevich; Scott C Weaver; Irina Tretyakova
Journal:  Expert Rev Vaccines       Date:  2016-04-25       Impact factor: 5.217

2.  Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.

Authors:  Irina Tretyakova; Igor S Lukashevich; Pamela Glass; Eryu Wang; Scott Weaver; Peter Pushko
Journal:  Vaccine       Date:  2012-12-31       Impact factor: 3.641

Review 3.  Epidemic Alphaviruses: Ecology, Emergence and Outbreaks.

Authors:  Sasha R Azar; Rafael K Campos; Nicholas A Bergren; Vidyleison N Camargos; Shannan L Rossi
Journal:  Microorganisms       Date:  2020-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.